RYTM — RHYTHM PHARMACEUTICALS, INC. CMN

Ownership history in FORA Capital, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which FORA Capital, LLC reported a position in RHYTHM PHARMACEUTICALS, INC. CMN (RYTM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2025 Q3)
Avg. % of fund
0.03%
First filed
2021 Q1
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 3,599 +2,514 +231.7% 0.06% $363K $100.99
2021 Q2 ADDED 1,085 +6 +0.6% 0.00% $21K $19.58
2021 Q1 INITIATED 1,079 — — 0.01% $23K $21.27
% of Fund (quarterly)    RYTM price (monthly, adj. close)

Other funds also holding RYTM

As of 2025 Q4 — sorted by position size

Checkpoint Capital L.P. 33.18% NEA Management Company, LLC 3Y 7Y 15.88% RA CAPITAL MANAGEMENT, L.P. 3Y 7Y 7.31% PERCEPTIVE ADVISORS LLC 3Y 7Y 4.86% Nan Fung Group Holdings Ltd 3Y 4.71% Opaleye Management Inc. 3Y 7Y 4.66% Sio Capital Management, LLC 3Y 7Y 4.47% Rock Springs Capital Management LP 3Y 7Y 3.81% BAKER BROS. ADVISORS LP 3Y 7Y 3.51% Integral Health Asset Management, LLC 3Y 2.52%
← Back to FORA Capital, LLC Holdings